So, Trametinib is this inhibitor that zeroes in on the MEK pathway. It’s mainly used for those BRAF V600E/K-mutant melanoma and NSCLC things. Its job is to put a stop to that MEK signaling.
It’s available in two strengths—there’s a 0.5 mg one and a 2 mg one, both as coated pills. You’re supposed to take the 2 mg tablet every day, but on an empty belly. The 2 mg pills come in bottles with 30 of ’em.
It’s supposed to help patients because it shuts down that overactive pathway they’ve got with these mutations. You’ve got to take it as told to get the right dose and the best effect.
